Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice
NCT03659110 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2018-09-27
Summary
This is a post-Approval Safety Monitoring Program to assess the safety profile of GARDASIL in china usual practice.
Conditions
Interventions
- BIOLOGICAL
-
HPV 4
1000 subjects will be received the HPV 4 vaccine
Sponsors & Collaborators
-
Beijing Chaoyang District Centre for Disease Control and Prevention
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2021-07-30
- Completion
- 2021-12-30
More Related Trials
-
Immunogenicity and Safety Study of NBP615 in Healthy Female
NCT04453241 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of HPV Vaccine in Thai Adult Women
NCT03763565 ·Status: COMPLETED
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls
NCT01173900 ·Status: COMPLETED ·Phase: PHASE4
-
Primary Cervical Cancer Screening by Self-sampling HPV Test
NCT05613283 ·Status: ACTIVE_NOT_RECRUITING
-
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
NCT04612660 ·Status: COMPLETED ·Phase: NA
-
HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
NCT06371118 ·Status: RECRUITING ·Phase: NA
-
DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2
NCT03870113 ·Status: UNKNOWN ·Phase: PHASE1
-
Acceptability of Self-sampling for Cervical Cancer Screening
NCT05314907 ·Status: UNKNOWN ·Phase: NA
-
Survival Outcomes of Uterine Cervical Malignancies in Chinese Population
NCT03291236 ·Status: UNKNOWN
-
Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda
NCT06536855 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection
NCT06467942 ·Status: RECRUITING ·Phase: NA
-
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
NCT00518336 ·Status: COMPLETED ·Phase: PHASE2
-
Reengineering Cervical Cancer Screening for the 21st Century: Joint Action for a Novel Up-to-date and Sustainable Screening Program
NCT06915610 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia
NCT05125380 ·Status: RECRUITING ·Phase: NA
-
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
NCT03613493 ·Status: TERMINATED ·Phase: NA
-
Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
NCT07033091 ·Status: RECRUITING ·Phase: NA
-
Pilot HPV Vaccination in Chinese American Community
NCT04505930 ·Status: COMPLETED ·Phase: NA
-
Clinical Implementation of Surface-guided Radiation Therapy in Vulvar Cancer
NCT05853549 ·Status: COMPLETED ·Phase: NA
-
Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV
NCT06456112 ·Status: NOT_YET_RECRUITING
-
Cervical Cancer Susceptible Population Classification
NCT06405945 ·Status: RECRUITING
-
Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
NCT07171658 ·Status: RECRUITING ·Phase: NA
-
The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research
NCT02018003 ·Status: UNKNOWN
-
HPV Integration Testing for Cervical Cancer Screening
NCT02576158 ·Status: UNKNOWN
-
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
NCT05414929 ·Status: UNKNOWN ·Phase: NA